The Role of Vpr and Vpx in Lentivirus Replication
The Role of Vpr and Vpx in Lentivirus Replication
批准号:
8659871
负责人:
Nathaniel R. Landau
金额:
$42.38万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-15 至 2018-06-30
关键词:
AddressAmino Acid SequenceAmino AcidsAntiviral AgentsBindingBiochemicalBiological AssayCell CycleCell NucleusCell physiologyCellsCo-ImmunoprecipitationsCollaborationsCoupledDNADendritic CellsDropsEffectivenessEngineeringEnzymesExonucleaseFlow CytometryFundingGoalsHIVHIV-1HIV-2HumanImmune responseImmune systemInfectionIntegration Host FactorsLaboratoriesLeukocytesLightLocationLymphoidMass Spectrum AnalysisMedicalMedical centerModelingMusMutateMyeloid CellsNatural ImmunityNucleotidesPathogenesisPhosphodiesterase IPhosphoric Monoester HydrolasesPlayPopulationPost Translational Modification AnalysisPost-Translational Protein ProcessingPropertyProteinsProteomicsRecombinantsRegulationResearchReverse TranscriptionRoleSamplingSubfamily lentivirinaeSystemTestingTetracyclinesUnited States National Institutes of HealthUniversitiesViral GenomeVirionVirusVirus Replicationbasebiobankcellular targetingclinical materialexperiencefightinggenetic regulatory proteinimmune activationin vitro Assayin vivoinfectious disease treatmentinorganic phosphateinsightmacrophagemonocytemutantnonhuman primatenucleasepathogenpreventpublic health relevancetransmission processtripolyphosphateubiquitin ligaseubiquitin-protein ligasevpr Gene Products
中文摘要
描述(由申请人提供):HIV-1和其他慢病毒编码辅助蛋白,每种辅助蛋白都在促进病毒复制和引起发病机制中起作用。一些辅助蛋白通过对抗抗病毒细胞蛋白发挥作用。这
英文摘要
DESCRIPTION (provided by applicant): HIV-1 and other lentiviruses encode accessory proteins, each of which plays a role in facilitating virus replication and causing pathogenesis. Several of the accessory proteins exert their effect by counteracting antiviral cell proteins. This
project focuses on understanding how the two HIV-related accessory proteins, Vpr and Vpx, facilitate virus replication. These proteins are 50% similar in amino acid sequence, are packaged in the virion, localize to the nucleus and bind a specific E3 ubiquitin ligase. Vpx, which
is encoded in HIV-2 and SIVmac but not HIV-1, targets the cellular enzyme SAMHD1 for degradation. The target of Vpr has not yet been identified. The mechanism by which SAMHD1 inhibits viruses is not clear. It is a phosphohydrolase that when expressed in myeloid cells, removes the phosphates from the deoxynucleotide triphosphates, depleting the pool of intracellular dNTPs. SAMHD1 is also an exonuclease and which of these activities restricts virus replication is not clear. SAMHD1 does not block the replication of SIVmac or HIV-2 as these viruses encode Vpx. This project seeks to understand (i) the mechanism by which SAMHD1 restricts HIV-1; (ii) how Vpx binds and targets SAMHD1 for degradation; (iii) how Vpx is released from the virus following infection; (iv) how the enzymatic activity of the protein is regulated by post-translational modifications or by associating with regulatory proteins; (v) which
amino acid residues of Vpx and SAMHD1 allow the proteins to interact; (vi) how Vpx is imported into the nucleus and (vii) the role of SAMHD1 in the innate immune response to HIV-1 infection. Lastly, an inducible expression system for Vpr will be established to identify the targeted host factor. The findings will shed light on a new mechanism by which the innate immune system restricts HIV-1 and other human pathogens and how viruses have evolved to escape the restriction. Understanding this may provide strategies to therapeutically enhance the effectiveness of the innate immune response for the treatment of infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic Dendritic Cell Vaccine for HIV
-
批准号:10089431
-
项目类别:
-
资助金额:$84.75万
-
财政年份:2018
-
负责人:Nathaniel R. Landau
-
依托单位:
Therapeutic Dendritic Cell Vaccine for HIV
-
批准号:10343711
-
项目类别:
-
资助金额:$84.75万
-
财政年份:2018
-
负责人:Nathaniel R. Landau
-
依托单位:
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
-
批准号:8679134
-
项目类别:
-
资助金额:$26.7万
-
财政年份:2013
-
负责人:Nathaniel R. Landau
-
依托单位:
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
-
批准号:8056761
-
项目类别:
-
资助金额:$16.88万
-
财政年份:2010
-
负责人:Nathaniel R. Landau
-
依托单位:
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
-
批准号:7926684
-
项目类别:
-
资助金额:$7.04万
-
财政年份:2009
-
负责人:Nathaniel R. Landau
-
依托单位:
Vpr Revisited
-
批准号:7425735
-
项目类别:
-
资助金额:$42.28万
-
财政年份:2007
-
负责人:Nathaniel R. Landau
-
依托单位:
The Role of Vpr and Vpx in Lentivirus Replication
-
批准号:9296016
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2007
-
负责人:Nathaniel R. Landau
-
依托单位:
Identification of Trim5alpha cofactors
-
批准号:7449609
-
项目类别:
-
资助金额:$12.46万
-
财政年份:2007
-
负责人:Nathaniel R. Landau
-
依托单位:
Vpr Revisited
-
批准号:7539215
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2007
-
负责人:Nathaniel R. Landau
-
依托单位:
Vpr Revisited
-
批准号:7995507
-
项目类别:
-
资助金额:$41.53万
-
财政年份:2007
-
负责人:Nathaniel R. Landau
-
依托单位:
The Role of Vpr and Vpx in Lentivirus Replication
-
批准号:9093670
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2007
-
负责人:Nathaniel R. Landau
-
依托单位:
Identification of Trim5alpha cofactors
-
批准号:7339569
-
项目类别:
-
资助金额:$34.39万
-
财政年份:2007
-
负责人:Nathaniel R. Landau
-
依托单位:
Vpr Revisited
-
批准号:7739475
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2007
-
负责人:Nathaniel R. Landau
-
依托单位:
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
-
批准号:8481499
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2004
-
负责人:Nathaniel R. Landau
-
依托单位:
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
-
批准号:8012631
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2004
-
负责人:Nathaniel R. Landau
-
依托单位:
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
-
批准号:7156203
-
项目类别:
-
资助金额:$13.56万
-
财政年份:2004
-
负责人:Nathaniel R. Landau
-
依托单位:
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
-
批准号:8082610
-
项目类别:
-
资助金额:$41.83万
-
财政年份:2004
-
负责人:Nathaniel R. Landau
-
依托单位:
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
-
批准号:6834590
-
项目类别:
-
资助金额:$41.9万
-
财政年份:2004
-
负责人:Nathaniel R. Landau
-
依托单位:
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
-
批准号:7450850
-
项目类别:
-
资助金额:$35.47万
-
财政年份:2004
-
负责人:Nathaniel R. Landau
-
依托单位:
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
-
批准号:8287114
-
项目类别:
-
资助金额:$41.83万
-
财政年份:2004
-
负责人:Nathaniel R. Landau
-
依托单位:
海外基金